Immune sabotage: How a Vitamin A byproduct compromises the body's normal anti-cancer response

Scientists at the Princeton University Branch of the Ludwig Institute for Cancer Research have identified novel mechanisms by which a metabolic derivative of vitamin A—all-trans retinoic acid—compromises both the body’s normal anti-cancer…

Continue Reading

News Source: medicalxpress.com